Journal of Inflammation Research
Volume 17, 2024 - Issue
ORIGINAL RESEARCH
FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization
, 
, &
Sizhe Zhu2 Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, People’s Republic of Chinahttps://orcid.org/0000-0002-2723-2704View further author information
https://orcid.org/0000-0002-2723-2704View further author information, & 